BRIEF published on 07/23/2026 at 11:10, 2 months 14 days ago FAMAR Appoints Bruce Vielle as New CEO Operational Excellence CEO Appointment Pharmaceutical Manufacturing FAMAR Bruce Vielle
BRIEF published on 07/23/2026 at 11:10, 2 months 14 days ago FAMAR nomme Bruce Vielle au poste de nouveau PDG Excellence Opérationnelle Nomination Du PDG Fabrication Pharmaceutique FAMAR Bruce Vielle
PRESS RELEASE published on 07/23/2026 at 11:05, 2 months 14 days ago FAMAR appoints Bruce Vielle as Chief Executive Officer FAMAR appoints Bruce Vielle as Chief Executive Officer effective 3 August 2026, succeeding Dr Riku Rautsola, with MidEuropa's strong commitment and focus on enhancing capabilities and customer support Appointment CEO FAMAR Bruce Vielle MidEuropa
BRIEF published on 05/19/2026 at 12:10, 4 months 17 days ago FAMAR Group Enters Agreement with GE HealthCare Contract Manufacturing GE HealthCare FAMAR Group Iodine-based Contrast Media Homburg Facility
BRIEF published on 05/19/2026 at 12:10, 4 months 17 days ago Le groupe FAMAR conclut un accord avec GE HealthCare Fabrication Sous Contrat GE Santé Groupe FAMAR Produits De Contraste À Base D'iode Installations De Homburg
PRESS RELEASE published on 05/19/2026 at 12:05, 4 months 17 days ago FAMAR Group announces contract manufacturing agreement with GE HealthCare FAMAR Group signs contract manufacturing agreement with GE HealthCare to fill and finish iodine-based contrast media vials in Homburg, Germany, expanding GE's manufacturing capacity for European customers Contract Manufacturing GE HealthCare FAMAR Group Contrast Media Homburg
BRIEF published on 09/29/2025 at 19:40, 1 year ago FAMAR Group Appoints Dr. Riku Rautsola as New CEO Global Expansion Pharmaceutical Industry CEO Appointment Leadership Change FAMAR Group
BRIEF published on 09/29/2025 at 19:40, 1 year ago Le groupe FAMAR nomme le Dr Riku Rautsola au poste de PDG Changement De Direction Expansion Mondiale Nomination Du PDG Industrie Pharmaceutique Groupe FAMAR
PRESS RELEASE published on 09/29/2025 at 19:35, 1 year ago FAMAR Group: Dr. Riku Rautsola Appointed New CEO FAMAR Group appoints Dr. Riku Rautsola as new CEO, replacing Konstantinos Rengis. Rautsola brings global leadership experience to drive growth and innovation Pharmaceutical Industry CEO Appointment Leadership Change FAMAR Group Dr. Riku Rautsola
Published on 10/05/2026 at 22:30, 12 hours 50 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 20 hours 35 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 20 hours 50 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 20 hours 50 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 21 hours 20 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/06/2026 at 11:05, 15 minutes ago Prophix® Announces Strategic Collaboration with PwC Belgium to Transform the Finance Function
Published on 10/06/2026 at 11:00, 20 minutes ago Original-Research: Power Metallic Mines Inc (von GBC AG): Buy
Published on 10/06/2026 at 10:05, 1 hour 15 minutes ago Playseat® Marks over 30 Years since Founding the Racing Cockpit Category
Published on 10/06/2026 at 10:05, 1 hour 15 minutes ago Brook StarRay Wireless Controller Now Available -- Native PS5 Support Meets Xbox-Style Control
Published on 10/06/2026 at 10:05, 1 hour 15 minutes ago Cognizant Selected by SITA to Deliver AI-Led Global Finance Transformation on the Cloud
Published on 10/05/2026 at 22:12, 13 hours 8 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 13 hours 8 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 17 hours 7 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 17 hours 7 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 17 hours 20 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
